跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31,505 条关于
“Second Opinion®”
全部
31,505
临床试验
21,050
药物
1,125
机构
82
资讯
9,248
去年
Pearl Achieves Historic FDA Clearance for First AI Platform Supporting Both 2D and 3D Dental Imaging Analysis
去年
Formycon's Aflibercept Biosimilar FYB203 Receives Positive CHMP Opinion for EU Approval
去年
Formycon's Aflibercept Biosimilar FYB203 Receives Positive CHMP Opinion for EU Approval
去年
InflaRx's Vilobelimab Receives Positive CHMP Opinion for COVID-19-Induced ARDS
去年
Formycon's Aflibercept Biosimilar, AHZANTIVE®/Baiama®, Receives Positive CHMP Opinion for EU Approval
4年前
Scemblix Receives Positive CHMP Opinion for CML Treatment After TKI Failure
2年前
Outlook Therapeutics Advances ONS-5010 Toward Potential First Approved Ophthalmic Bevacizumab for Retinal Diseases
去年
CHMP Recommends Mirvetuximab Soravtansine (ELAHERE®) for Platinum-Resistant Ovarian Cancer
去年
CHMP Recommends Daratumumab-Based Quadruplet Regimen for Newly Diagnosed Multiple Myeloma
去年
InflaRx's Vilobelimab Receives Positive CHMP Opinion for SARS-CoV-2-Induced ARDS
第 1 页,共 925 页
上一页
下一页